M Nauck, A Frid, K Hermansen, NS Shah, T … - Diabetes Care, 2009 - Am Diabetes Assoc RESULTS—A1C values were significantly reduced in all liraglutide groups versus
the placebo group (P < 0.0001) with mean decreases of 1.0% for 1.8 mg
liraglutide, 1.2 mg liraglutide, and glimepiride and 0.7% for 0.6 mg ... Cited by 47 - Related articles - All 4 versions
A Garber, R Henry, R Ratner, PA Garcia- … - The Lancet, 2009 - Elsevier In a double-blind, double-dummy, active-control, parallel-group study, 746
patients with early type 2 diabetes were randomly assigned to once daily
liraglutide (1·2 mg [n=251] or 1·8 mg [n=247]) or glimepiride 8 mg ... Cited by 53 - Related articles - All 46 versions
M Marre, J Shaw, M Brandle, WM Bebakar, NA … - Diabetic Medicine, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 24 - Related articles - All 3 versions
DJ Drucker, JB Buse, K Taylor, DM Kendall, M … - The Lancet, 2008 - Elsevier A 30-week, randomised, non-inferiority study compared a long-acting release
formulation of exenatide 2 mg administered once weekly to 10 μg exenatide
administered twice a day, in 295 patients with type 2 diabetes (haemoglobin ... Cited by 36 - Related articles - All 4 versions
B Zinman, J Gerich, JB Buse, A Lewin, S … - Diabetes Care, 2009 - Am Diabetes Assoc Results –— Mean HbA1c values decreased significantly more in the liraglutide
groups vs. placebo (–1.5±0.1% for both liraglutide 1.2 and 1.8mg and
–0.5±0.1% for placebo [values±SE]). Fasting plasma glucose decreased by ... Cited by 23 - Related articles - All 3 versions
[CITATION] Effect of the GLP-1 analogue liraglutide on glycaemic control and weight reduction in …
B Zinman, J Gerich, J Buse, A Lewin, SL … - European Association for the Study of Diabetes, 2008 Cited by 20 - Related articles
TJ Moretto, DR Milton, TD Ridge, LA … - Clinical Therapeutics, 2008 - Elsevier Methods: This 24-week, double-blind, placebo-controlled, parallel-group study
was conducted at 23 centers across the United States, Puerto Rico, Romania,
Russia, and India. Patients aged ≥18 years with type 2 diabetes were ... Cited by 16 - Related articles - All 2 versions
[CITATION] Significantly better glycaemic control/weight reduction with human GLP-1 analogue liraglutide …
JB Buse, J Rosenstock, G Sesti, WE Schmidt, … - The Lancet, 2009 - Elsevier Mean baseline HbA 1c for the study population was 8·2%. Liraglutide reduced
mean HbA 1c significantly more than did exenatide (−1·12% [SE 0·08] vs
−0·79% [0·08]; estimated treatment difference −0·33; 95% CI −0·47 ... Cited by 15 - Related articles - All 25 versions
